Template:Cholangiocarcinoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(11 intermediate revisions by 3 users not shown)
Line 76: Line 76:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Cholangiocarcinoma natural history|Natural History, Complications and Prognosis]]
[[Cholangiocarcinoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 88: Line 88:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Cholangiocarcinoma staging|Staging]]
[[Cholangiocarcinoma diagnostic study of choice|Diagnostic Study of Choice]]
|-  
|-  
!
!
Line 113: Line 113:
!
!
[[Cholangiocarcinoma electrocardiogram|Electrocardiogram]]
[[Cholangiocarcinoma electrocardiogram|Electrocardiogram]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Cholangiocarcinoma x ray|X-ray]]
|-  
|-  
!
!
Line 130: Line 136:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Cholangiocarcinoma echocardiography or ultrasound|Abdominal Ultrasound]]
[[Cholangiocarcinoma echocardiography or ultrasound|Echocardiography or Ultrasound]]
 
[[Cholangiocarcinoma other imaging findings#Endoscopic Ultrasound|Endoscopic Ultrasound]]
|-  
|-  
!
!
Line 138: Line 142:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Cholangiocarcinoma other imaging findings#ERCP|ERCP]]
[[Cholangiocarcinoma other imaging findings|Other Imaging Findings]]
 
[[Cholangiocarcinoma other imaging findings#MRCP|MRCP]]
 
[[Cholangiocarcinoma other imaging findings#Percutaneous Transhepatic Cholangiography|PTC]]
|-  
|-  
!
!
Line 160: Line 160:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Cholangiocarcinoma medical therapy#Adjuvant chemotherapy and radiation therapy|Adjuvant chemotherapy and radiation therapy]]
[[Cholangiocarcinoma medical therapy|Medical Therapy]]
|-  
|-  
!
!
Line 167: Line 167:
!
!
[[Cholangiocarcinoma surgery|Surgery]]
[[Cholangiocarcinoma surgery|Surgery]]
[[Cholangiocarcinoma surgery#Liver Transplant|Liver Transplant]]
|-  
|-  
!
!
Line 174: Line 172:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Cholangiocarcinoma medical therapy#Treatment of advanced disease|Treatment of advanced disease]]
[[Cholangiocarcinoma primary prevention|Primary Prevention]]
|-  
|-  
!  
!  
Line 180: Line 178:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Cholangiocarcinoma primary prevention|Primary Prevention]]
[[Cholangiocarcinoma secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!  
Line 186: Line 184:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Cholangiocarcinoma secondary prevention|Secondary Prevention]]
[[Cholangiocarcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 192: Line 190:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Cholangiocarcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Cholangiocarcinoma future or investigational therapies|Future or Investigational Therapies]]
|-  
!
 
|- bgcolor="CadetBlue"
!
Case Studies
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Cholangiocarcinoma future or investigational therapies|Future or Investigational Therapies]]
[[Cholangiocarcinoma case study one|Case #1]]
|-  
|-  
!  
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "

Latest revision as of 17:50, 7 January 2019